Bob Casale

PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX.

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.

First Aid Beverages, Inc. develops and commercializes comprehensive portfolio of over-the-counter pharmaceutical products. It develops liquid formulated single-dose products for treating pain and upset stomach symptoms. The company was founded by Mary Page Platerink and Jay Pasricha in 2010 and is headquartered in Burlingame, CA.

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of a technology platform for approved drugs. It offers the PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Dover, DE.

Alitair Pharmaceuticals, Inc. discovers, invents and develops medicines for the treatment of respiratory illnesses. It develops orphan drugs for bronchiectasis and also has products under development for prescription and over-the-counter cough treatment. The company is headquartered in Morristown, NJ.

Insight Pharmaceuticals LLC manufactures and markets non-prescription medications and personal care products. It offers cepastat, allerest, chooz, kondremul, auro, bonine, caldecort, tanac, ting, monistat, dermarest and uristat. The company was founded in 1996 and is headquartered in Trevose, PA.

Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ.